FTY720 suppresses CD4+CD44highCD62L- effector memory T cell-mediated colitis

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 291, Issue 2, 2006, Pages

  Fujii, R ^a   Kanai, T ^a   Nemoto, Y ^a   Makita, S ^a   Oshima, S ^a   Okamoto, R ^a   Tsuchiya, K ^a   Totsuka, T ^a   Watanabe, M ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

I cell; Migration; Therapy

Indexed keywords

FINGOLIMOD; GAMMA INTERFERON; HERMES ANTIGEN; IMMUNOMODULATING AGENT; INTERLEUKIN 2; PADGEM PROTEIN; PHOSPHATE; SPINGOSINE 1 PHOSPHATE RECEPTOR; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD CELL COUNT; CD4 LYMPHOCYTE COUNT; COLITIS; CONTROLLED STUDY; DOSE RESPONSE; DRUG ACTIVITY; DRUG INHIBITION; DRUG MECHANISM; ENTERITIS; FEMALE; IMMUNE DEFICIENCY; LAMINA PROPRIA; MEMORY T LYMPHOCYTE; MESENTERY LYMPH NODE; NONHUMAN; PRIORITY JOURNAL; SPLEEN;

ANIMALS; ANTIGENS, CD4; ANTIGENS, CD44; COLITIS; FEMALE; IMMUNOLOGIC MEMORY; IMMUNOSUPPRESSIVE AGENTS; INFLAMMATION MEDIATORS; L-SELECTIN; MICE; MICE, INBRED BALB C; MICE, SCID; PROPYLENE GLYCOLS; SPHINGOSINE;

EID: 33745767310     PISSN: 01931857     EISSN: 15221547     Source Type: Journal    
DOI: 10.1152/ajpgi.00496.2005     Document Type: Article

References (32)

1. Brinkmann V, Cyster JG, and Hla T. FTY720: sphingosine 1-phosphate receptor-1 in the control of lymphocyte egress and endothelial barrier function. Am J Transplant 4: 1019-1025, 2004.
2. Brinkmann V and Lynch KR. FTY720: targeting G-protein-coupled receptors for sphingosine 1-phosphate in transplantation and autoimmunity. Curr Opin Immunol 14: 569-575, 2002.
3. Chiba K, Hoshino Y, Suzuki C, Masubuchi Y, Yanagawa Y, Ohtsuki M, Sasaki S, and Fujita T. FTY720, a novel immunosuppressant possessing unique mechanisms. I. Prolongation of skin allograft survival and synergistic effect in combination with cyclosporine in rats. Transplant Proc 28: 1056-1059, 1996.
4. Chiba K, Yanagawa Y, Masubuchi Y, Kataoka H, Kawaguchi T, Ohtsuki M, and Hoshino Y. FTY720, a novel immunosuppressant, induces sequestration of circulating mature lymphocytes by acceleration of lymphocyte homing in rats. I. FTY720 selectively decreases the number of circulating mature lymphocytes by acceleration of lymphocyte homing. J Immunol 160: 5037-5044, 1998.
5. Cyster JG. Chemokines, sphingosine-1-phosphate, and cell migration in secondary lymphoid organs. Annu Rev Immunol 23: 127-159, 2005.
6. Fujita T, Inoue K, Yamamoto S, Ikumoto T, Sasaki S, Toyota R, Chiba K, Hoshino Y, and Okumoto T. Fungal metabolites. II. A potent immunosuppressive activity found in Isaria sinclairii metabolite. J Antibiot (Tokyo) 47: 208-215, 1994.
7. Gowans JL and Knight EJ. The route of re-circulation of lymphcytes in the rat. Proc R Soc Lond B Biol Sci 159: 257-282, 1964.
8. Graler MH and Goetzl EJ. The immunosuppressant FTY720 downregulates sphingosine 1-phosphate G protein-coupled receptors. FASEB J 18: 551-553, 2004.
9. Henning G, Ohl L, Junt T, Reiterrer P, Brinkmann V, Nakano H, Hohenberger W, Lipp M, and Forster R. CC chemokine receptor 7-dependent and -independent pathways for lymphocyte homing: modulation by FTY720. J Exp Med 194: 1875-1881, 2001.
10. Kanai T, Totsuka T, Uraushihara K, Makita S, Nakamura T, Koganei K, Fukushima T, Akiba H, Yagita H, Okumura K, Machida U, Iwai H, Azuma M, Chen L, and Watanabe M. Blockade of B7-H1 suppresses the development of chronic intestinal inflammation. J Immunol 171: 4156-4163, 2003.
11. Kitabayashi H, Isobe M, Watanabe N, Suzuki J, Yazaki Y, and Sekiguchi M. FTY720 prevents development of experimental autoimmune myocarditis through reduction of circulating lymphocytes. J Cardivasc Pharmacol 35: 410-416, 2000.
12. MacDonald TT and Pender SLF. Lamina propria T cells. Chem Immunol 71: 103-117, 1998.
13. Mandala S, Hajdu R, Bergstrom J, Quackenbush E, Xie J, Milligan J, Thornton R, Shei GJ, Card D, Keohane C, Rosenbach Hale J M, Lynch CL, Rupprecht K, Parsons W, and Rosen H. Alteration of lymphocyte trafficking by sphingosine-1-phosphate receptor agonists. Science 296: 346-349, 2002.
14. Masopust D, Vezys V, Marzo AL, and Lefrancois L. Preferential localization of effector memory T cells in nonlymphoid tissue. Science 291: 2413-2417, 2001.
15. Matoubian M, Lo CG, Cinamon G, Lessneski MJ, Xu Y, Brinkmann ML, Allende ML, Proia RL, and Cyster JG. Lymphocyte egress from thymus and peripheral lymphoid organs is depedent on S1P receptor. Nature 427: 355-360, 2004.
16. Matsuura M, Imayoshi T, and Okumoto T. Effect of FTY720, a novel immunosuppressant, on adjuvant- and collagen-induced arthritis in rat. Int J Immunopharmacol 22: 323-331, 2000.
17. Miyamoto T, Matsumori A, Hwang MW, Nishio R, Ito H, and Sasayama S. Therapeutic effects of FTY720, a new immunosuppressive agent, in a murine model of acute viral myocarditis. J Am Coll Cardiol 37: 1713-1718, 2001.
18. Mizushima T, Ito T, Kishi D, Kai Y, Tamagawa H, Nezu R, Kiyono H, Matsuda H. Therapeutic effects of a new lymphocyte homing reagent FTY720 in interleukin-10 gene-deficient mice with coltis. Inflamm Bowel Dis 10: 182-192, 2004.
19. + regulatory T cells. J Immunol 170: 3939-3943, 2003.
20. Okazaki H, Hirata D, Kamimura T, Sato H, Iwamoto M, Yoshio T, Matsuyama J, Fujimura A, Kobayashi E, Kano S, and Minota S. Effects of FTY720 in MRL-lpr/lpr mice: therapeutic potential in systemic lupus erythematosus. J Rheumatol 29: 707-716, 2002.
21. Pinschewer DD, Ochsenbein AF, Odematt B, Brinlmann V, Hengartner H, and Zinkernagel RM. FTY720 immunosuppression impairs effector T-cell peripheral homing without affscting induction, expansion, and memory. J Immunol 164: 5761-5770, 2000.
22. Rosen H, Sanna G, and Alfonso C. Egress: a receptor-regulated step in lymphocyte trafficking. Immunol Rev 195: 160-177, 2003.
23. Schuurman HJ, Menninger K, Audet M, Kunkler A, Maurer C, Vedrine C, Bernhard M, Gaschen L, Brinkmann V, and Quesniaux V. Oral efficacy of the new immunomodulator FTY720 in cynomolgus monkey kidney allotransplatation, given alone or in combination with cyclosporine or RAD. Transplantation 74: 951-960, 2002.
24. Sallusto F, Lenig D, Forster R, Lipp M, and Lanzavecchia A. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 401: 708-712, 1999.
25. Singh B, Read S, Asseman C, Malmstrom V, Mottet C, Stephens LA, Stepankova R, Tlaskalova H, and Porwrie F. Control of intestinal inflammation by regulatory T cells. Immunol Rev 182: 190-200, 2001.
26. Spiegel S and Milstien S. Sphingosine-1-phosphate: an enigmatic signaling lipid. Nat Rev Mol Cell Biol 4: 397-407, 2003.
27. Suzuki S, Enosawa S, Kakefuda T, Shinomiya T, Amari M, Naoe S, Hoshino Y, and Chiba K. A novel immunosuppressant, FTY720, with a unique mechanism of action, induces long-term graft acceptance in rat and dog allotransplantation. Transplantation 61: 200-205, 1996.
28. Tamura A, Li XK, Funeshima N, Enosawa S, Amemiya H, Kitajima K, and Suzuki S. Immunosuppressive therapy using FTY720 combined with tacrolimus in rat liver transplantation. Surgery 127: 47-54, 2000.
29. Totsuka T, Kanai T, Iiyama R, Uraushihara K, Yamazaki M, Okamoto R, Hibi T, Tezuka K, Azuma M, Akiba H, Yagita H, Okumura K, and Watanabe M. Ameliorating effect of anti-ICOS monoclonal antibody in a murine model of chronic colitis. Gastroenterology 124: 410-421, 2003.
30. Wang ME, Tejpal N, Qu X, Yu J, Okamoto M, Stepkowski SM, and Kahan BD. Immunosuppressive effects of FTY720 alone or in combination with cyclosporine and/or sirolimus. Transplantation 65: 899-905, 1998.
31. Yanagawa Y, Sugahara K, Kataoka H, Kawaguchi T, Masubuchi Y, and Chiba K. FTY720, a novel immunosuppressant, induces sequestration of circulating mature lymphocytes by acceleration of lymphocyte homing in rats. II. FTY720 prolongs skin allograft survival by decreasing T cell infiltration into grafts but not cytokine production in vivo. J Immunol 160: 5493-5499, 1998.
32. Yoffey JM. Variation in lymphocyte production. J Anat 70: 507-514, 1936.